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Abstract 
Current standard methods to calculate the dose of radiation emitted during medical applications 
by beta-minus emitting microspheres rely on an over-simplistic formalism. This formalism is 
a function of the average activity of the radioisotope used and the physiological dimensions of 
the patient only. It neglects the variation in energy of the emitted beta particle due to self-
attenuation, or self-absorption, effects related to the finite size of the sphere. Here it is assumed 
the sphere is comprised of a pure radioisotope with beta particles being emitted isotropically 
throughout the material. The full initial possible kinetic energy distribution of a beta particle is 
taken into account as well as the energy losses due to scattering by other atoms in the 
microsphere and bremsstrahlung radiation. By combining Longmire’s theory of the mean 
forward range of charged particles and the Rayleigh distribution to take into account the 
statistical nature of scattering and energy straggling, the linear attenuation, or self-absorption, 
coefficient for beta-emitting radioisotopes has been deduced. By analogy with gamma radiation 
transport in spheres, this result was used to calculate the rate of energy emitted by a beta-
emitting microsphere and its efficiency. Comparisons to standard point dose kernel 
formulations generated using Monte Carlo data show the efficacy of the proposed method. 
Yttrium-90 is used as a specific example throughout, as a medically significant radioisotope, 
frequently used in radiation therapy for treating cancer. 
 
Keywords 
Self-absorption; beta-decay; dosimetry; Y-90; P-33; Lu-177; microspheres; mass attenuation 
 
1. Introduction  
Beta-minus emitting radioactive microspheres are increasingly used in medical applications 
such as PET/SPECT imaging [1-4] and radiation therapy [5-12] as they often offer advantages 
over alternative methods such as chemoembolization and external beam radiation [13-14]. For 
instance, in radioembolization [6, 8, 15] or Selective Internal Radiation Therapy (SIRT) [16], 
radioactive microspheres are delivered to a tumour through the bloodstream via a catheter prior 
to an angiogram. The particles lodge in the tumour and emit radiation that kills the tumour. 
This method of cancer treatment is commonly used in conjunction with more well-established 
treatments such as chemotherapy. While this method offers advantages over external beam 
radiation, there is still a danger of complication due to extrahepatic deposition of the radioactive 
material [17-20]. To minimise the potential of further injury, the dose of radiation delivered to 
the patient needs to be well controlled [18, 21]. However, the absorbed dose, as described by a 
widely used formalism [7, 22, 23], is a function of the expected activity and pertinent 
physiological dimensions only, which does not include the variation in energy of the emitted 
electron due to self-attenuation effects related to the finite size of the particle.  
There are many types of radionuclides used in medicine and generally are used as spheres of 
various sizes and compositions [24-29]. The energy of the electrons emitted by these 
radioactive microspheres can vary over several orders of magnitude and for lower energy 
electrons, energy loss within the microsphere can be significant. This effect can be 
compounded if the microspheres cluster during radioimmunotherapy [30-31].  
The electrons lose energy as they travel through the microsphere due to interactions and 
collisions with atoms [32, 33]. During these interactions, atoms can absorb energy, slowing 
down the electron and deflecting it from its original trajectory. This is self-attenuation. The 
deflection of the electrons trajectory is mainly due to elastic scattering, inelastic scattering, 
ionization and Bremsstrahlung radiation. There are other scattering processes and loss 
mechanisms such as Moller scattering etc. but these are relatively unimportant [32]. Elastic 
scattering occurs due to Coulomb interactions between the electron and an atomic nucleus 
screened by the atomic electrons. Elastic scattering does not result in a loss of energy in the 
electron and leaves the atom undisturbed. During an inelastic interaction, or excitation, the 
incident electron interacts with atomic electrons. This can raise the atomic electron into an 
excited state while the original continues with reduced energy. During ionization, the incident 
electron knocks out one of the atomic electrons, thus ionising the atoms. Bremsstrahlung 
radiation can be emitted when the electron is briefly accelerated as it is being deflected. The 
accompanying energy loss in the form of photons is possibly significant only at relativistic 
energies, i.e. >1 MeV [33]. As the emitted electron passes through matter, it will interact with 
many atoms along its path. The electrons trajectory will therefore deviate from its original 
straight-line path, losing energy due to excitation and ionization and given enough material, 
eventually come to rest. Therefore, the true energy emitted by a radioactive particle is not just 
a function of its activity but of its size as well [34]. This is captured within a self-attenuation 
coefficient which is characteristic of the radioactive material. Measurement of this coefficient 
is non-trivial as many factors need to be taken into account. To this end, a number of 
researchers are still trying to generate accurate empirical relationships for the related mass 
attenuation coefficient albeit for non-radioactive absorbers [35, 36].   
Calculations on the energy lost by beta particles have largely been focussed on aqueous media 
because of the important medical implications [37-39]. These models are generally formulated 
using either solutions of the transport equations [40, 41], Monte Carlo calculations [39, 42-43], 
or convolutions of tabulated data from experimental sources such as thin foil [44] or 
PET/SPECT measurements [45, 46]. Each of these methods have their advantages and 
limitations. Solving the transport equations, as is used here for instance, is a fast and robust 
method but without the previously mentioned mass attenuation coefficients and analytical 
solutions for the spherical geometry, requires significant numerical calculations [41]. 
Similarly, Monte Carlo methods have been very successfully used in dosimetry, but require 
substantial computational effort to generate sufficient data sets [42, 43]. Fortunately codes such 
as FLUKA [47] and Geant4 [48] are becoming increasingly robust and sophisticated and are 
being adapted for this purpose. Monte Carlo calculations are frequently used to generate ‘point 
dose kernels’ which are non-physical functions fitted to the numerical data to represent the 
energy absorbed by various, usually aqueous, media upon exposure to a point beta particle 
source. These kernels could then be used to numerically calculate the dose due to exposure to 
multiple or distributed sources. One of the most frequently cited references was by Berger [37] 
who used the ETRAN code to simulate monoenergetic electrons and produced dose point 
kernels that took into account multiple Coulomb scattering and energy transport by 
bremsstrahlung production. This work was extended by Prestwich et al. [41] who calculated 
the pose point kernels for six radionuclides of interest in nuclear medicine (Y-90, P-32, Cu-67, 
I-131, Re-186 and Re-188) considering only beta particle emission but took into account the 
full energy spectrum. More recently, Cross [49] proposed empirical calculations of doses 
delivered by point sources at a distance. Most of the codes used to generate the point source 
data are limited by the validity of the multiple diffusion theory at low energies and therefore 
are rarely applicable below 1-20 keV [50]. These point dose kernels are rarely amenable to 
analytical calculation unless they are in a convenient form [51, 52].     
In this paper, the power emitted by a radioactive sphere, and hence its activity, is calculated. 
Expressions developed by Fermi [53, 54] for the energy distribution of the electron 
immediately after decay including correction factors that include the effect of Coulomb 
interactions are used to determine the initial activity. The deviation of the trajectory of the 
electrons caused by multiple scattering and the energy loss due to ionization and excitation are 
calculated assuming a continuum model whereby scattering processes are continuous and not 
discreet. This model is used to calculate the change in the energy distribution of the electrons 
as they travel through the material and by fitting an exponential model to this data, the self-
absorption coefficient is determined. By analogy with an analytical solution recently developed 
for a spherical gamma emitter by Atkinson and Brezovich [55], the total power output and 
efficiency of a beta-emitting microsphere is calculated. While the theory presented can be 
applied to any beta emitting sphere for any application, the specific case of a sphere composed 
of pure Yttrium-90, or Y-90, will be considered as an example. This is because Y-90 is a 
medically significant isotope of Yttrium frequently used in radiation therapy for treating 
cancer. Results are compared to point dose kernel formulations generated by fitting functional 





During beta-minus decay, as considered here, a neutron converts to a proton causing two 
particles to be ejected from the nucleus: the electron and the antineutrino. In the case of Y-90, 
which has an atomic number, Z, of 39, the result is an isotope of Zirconium, Z-90 with an 
atomic number, Z’, of 40. The available kinetic energy released by the reaction is divided 
between the antineutrino and the electron. Therefore, the kinetic energy of the emitted electron, 
T , can take any value less than the maximum kinetic energy available, Q , given by [32]: 
 2 2 2 21 2 eQ M c M c m c m cν= − − −   (1) 
1M  is the nuclear mass of the original parent nucleus, 2M is the nuclear mass of the daughter 
nucleus after decay and em is the mass of the electron. The mass of the antineutrino, mν , is 
vanishingly small. c is the speed of light. For Y-90, 2.2798 MeVQ = [56]. To first order, the 
distribution of kinetic energies that emitted electrons that be expected to possess is given by 
Fermi’s theory of beta decay as [32, 33]: 
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= + − +   (2) 
where ( )22 3 72fiC g M cπ=  , g  is the weak interaction constant, fiM  is the nuclear matrix 
element as defined in [32] and   is the reduced Planck’s constant. m  is the mass of the electron 
(the subscript will be dropped hereafter). This expression neglects two important factors which 
causes it to deviate significantly from the experimentally observed distribution. The first factor 
arises from the Coulomb interaction between the electron and the daughter nucleus which was 
neglected in Eq. 2. The Coulomb interaction causes an attraction of the electron to the daughter 
nucleus resulting in more low-energy electrons. A correction for this can be added to Eq. 2 in 
the form of the Fermi function [53, 54]: 
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where ( )1/22 21 'S Zα= − , / ( / )R mcρ =  , R is the nuclear radius, p is the electron momentum, 
'Z is the nuclear charge on the daughter nucleus, α is the fine structure constant and 
2' /Z e vη =   where v is the speed of the electron far away from the nucleus. W is the total 
energy (kinetic plus rest energy) corresponding to momentum p in units of mc2 and mc 
respectively. In order to simplify calculations, Nilsson derived an expression with an error of 
one-half percent at most [57]: 
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with 2 'a Zπα= , / (1 )ab a e−= − , C b a= −  and 1 ( 1)
2
d b= − . The second factor arises from the 
‘forbiddenness’ of the nuclear decay. A ‘forbidden’ decay does not mean the decay is 
impossible but rather is less probable than allowed decays and so may have a longer half-live. 
An allowed decay is described by eq. 2 which was derived by taking just the first term in the 
Taylor expansion of the wavefunctions describing the nucleus, antineutrino and electron during 
decay. When decays are forbidden, higher order terms need to be included as well, with the 
significance of each term being weighted by the proportion of experimentally observed decays 
with the pertinent half-life. For instance, 99.983% of Y-90 decays falls into the unique 1st 
forbidden category [58]. Therefore, Eq. 2 needs to be further modified by a ‘shape factor’ which 
includes the higher order terms of the wavefunctions. In this case, the correction is [59]: 
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with 0.2 ~ 0.3Sb = , taken in this case to be 0.25. Note S  is in units of 1m c= = = . q is the 
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The energy distribution of Y-90 can therefore be given as: 
 ( ) ( ) ( ', )CN T N T F Z W S=   (7) 
This distribution is shown in Fig. 1: 
 
Fig. 1: Expected electron energy distribution for Y-90. 
Note the average kinetic energy calculated from this spectrum is 927.4 keV, which is very close 
to 926.7 keV as given in [58], and with 
2
fiM set at 5.56x10-5 in eq. 2, the half-life can be 
calculated to be 2.6684 days as expected [56]. As the emitted electrons travel through the 
material, they will interact with atomic electrons through Coulomb scattering. This scattering 
causes the emitted electron to follow erratic paths so that the range (defined as the linear 
distance of penetration into the material [32]) is very different to the actual length of the path 
taken. The electron, which initially may be travelling at relativistic speeds, may, as a result of 
collisions with atomic electrons, experience rapid changes of direction and speed. This results 
in high accelerations, and being charged, the electrons emit electromagnetic energy or 
bremsstrahlung radiation. Therefore two sources of energy dissipation must be considered, that 
due to momentum exchange during collisions and that due to radiation. Bethe derived 
expressions for both cases in the form of energy loss per unit length [32]:      
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where x is in the direction of the electrons path. Z and A  are the atomic number and atomic 
mass of the material the electron is travelling through respectively, which is taken to be pure 
Y-90 in this case. e  is the charge of an electron, AN  is Avogadro’s number, ρ  is the density 
of Y-90, v cβ =  and I  is the ionization energy of Y-90 taken to be 379 eV [60]. The subscripts 
c and r stand for the energy losses due to collisions and bremsstrahlung radiation respectively. 
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The relative contributions of these energy losses is shown in Fig. 2. 
 
Fig. 2: Expected energy loss by electrons in Y-90. 
In reality, electrons lose energy at more or less than the average rate given by Eq. 10. Assuming 
that electrons lose energy at this average rate is known as the continuous slowing down 
approximation and permits investigation without resorting to statistical analysis. As well as 
losing energy, this scattering naturally leads to a change in direction, an effect which increases 
in importance for lower energy electrons. The path taken by the electron is akin to a directed 
random walk with multiple scattering often dominating the electrons motion. Initially, while 
still at high energies, the scattering causes a slow divergence in angle from the initial path. At 
lower energies the angle of scattering is larger and the deviation from the original path can be 
significant. Using the Williams theory of scattering which is based on Rutherford’s theory for 
individual electron-atom scattering, the rate of change of the mean square scattering angle, 
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where 21= +T mcγ and maxθ is the maximum angle that is considered ‘small’ during a single 
scattering. sθ can be considered the smallest angle that a neutral atom can scatter an electron 
due to the shielding effects of the atomic electrons and the finite size of the atom which negates 
the singularities in Rutherford’s theory. There are a number of ways to choose sθ and maxθ . Here 
the same approach as taken in [33, 61] is used, i.e.: 
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  (13) 
The rate of increase of the mean square scattering angle with respect to the decrease in kinetic 
energy of the electron can be defined as: 
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Longmire [62] was able to gain an analytical expression for Eq. 14, but neglected the radiative 
losses. Here Eq. 14 is solved numerically to find the mean square scattering angle. In the same 
publication, Longmire also extended Williams theory in order to calculate the mean forward 
range which is the mean distance travelled in the direction of an initially collimated beam by a 
population of electrons with the same initial energy. This theory gives the range of an electron 
with initial energy 0T undergoing multiple scattering and experiencing collisional and radiative 
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where 21 0.5η θ= + . In Fig. 3, the effect of scattering is clear. An electron emitted with the 
maximum allowed initial kinetic energy from within a large body of Y-90 will follow a path 
with an average length of 2.9 mm. However, as this path will been deflected many times due 
to scattering, the mean distance the electron will have travelled in the direction of its initial 
trajectory is just c.a. 700 µm.   
 
Fig. 3: (left) the loss of kinetic energy of a beta particle with initial kinetic energy Q as a 
function of the true expected distance travelled and (right) the loss of kinetic energy of a 
beta particle with initial kinetic energy Q as a function of the expected projected 
distance travelled in the direction of the initial trajectory. 
From Eq. 15, the following range-energy relationship for the beta particles emitted in Y-90 can 
be calculated: 
 
Fig. 4: Range-energy relationship for the beta particles in Y-90. 
As mentioned above, the energy loss of a beta particle is a probabilistic process and so an actual 
beta particle may travel somewhat more or less than given by Eq. 15. To account for this, it is 
assumed that the differential range distribution of the beta particles obeys the Rayleigh 
distribution, which can be given as [63]: 
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where R is the mean range as given by Eq. 15 and x is the thickness of the material. The 
probability the beta particle will travel at least a distance x is therefore: 
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As the beta particle are emitted with a distribution of possible energies, as given by Eq. 7, they 
will have a distribution of possible mean ranges as shown in Fig. 4. Therefore, the energy 
distribution is divided into groups described by a probability mass function so that the ith group 
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where k is the total number of groups. The relative emitted intensity, i.e. the proportion of beta 





















  (19) 
In this way, the energy spectrum can be represented thus: 
 
Fig. 5: Probability mass function (PMF) of the relative intensity of beta particles for a 
given kinetic energy iT . The red line denotes the continuous relative energy distribution 
given by Eq. 7. Note k = 10 for this figure, however it was 1000 during subsequent 
calculations.  
The relative intensity ( )in x  of electrons from the ith group passing through the material with 
thickness x is: 
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  (20) 
Fitting an exponential curve of the form: 
 ( )expFit C xµ= −   (21) 
where C  is an arbitrary constant and µ  is the linear attenuation coefficient (in cm-1) , to the 
lower portion of Eq. 20 (it was found that fitting to ( ) 0.8i in x I<  gave the best fit) permits the 
calculation of µ . Given the linear attenuation coefficient was calculated with Y-90 as the 
absorber, this is by definition also the self-attenuation coefficient for Y-90. As is common 
practice, dividing µ  by the density of yttrium gives the mass attenuation coefficient in units 
of cm2g-1. The result is shown in Fig. 6. The calculated mass attenuation coefficient of Y-90 
can be compared to a power-law approximation of the same form used by Thontadarya for an 
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where T  is in MeV. The relative error between that calculated using Eq. 21 and the 
approximate expression given by Eq. 22 is less than 5% for energies above 10 keV. Below 10 
keV, the relative error increases to 15% 
 
Fig. 6: The mass attenuation coefficient of electrons in Yttrium. 
Y-90 has a theoretical activity density, or number of decay events per unit volume per second, 
of 9x105 GBq/cc and a theoretical power density, or energy produced per unit volume per 
second, of 13.4 kW/cc. These densities are very high for beta sources and are due to the 
materials high energy decay and relatively short half-life. Denoting the activity density as MA , 
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where R  is the radius of the sphere. This result gives the number of electrons that will enter a 
tissue should a sphere of radius R  comprised of pure Y-90 be encapsulated in it. As these 
electrons will have been emitted with a distribution of energies, it is necessary to also know 
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In Fig. 7, the results of Eqtns. 23 and 24 in terms of the number of electrons per second emitted 
from spheres of increasing radii and the associated power emitted are shown. Also shown are 
the number of electrons and power initially generated through radioactive decay in these 
spheres. As can be seen the number of electrons and power initially generated increase with 
the cube of the radius or volume of the sphere as expected. However, the number of electrons 
and the associated power that actually reach the spheres surface and is emitted increases at a 
slower rate. This is due to the attenuation and its effects are shown more clearly in Fig. 8. The 
efficiency of the radioactive microspheres is defined in this instance as the power emitted 
divided by the power initially generated. As can be seen, when the spheres reach c.a. 940 µm, 
the efficiency has dropped to 50 % meaning that half the energy available has been absorbed 
by the sphere itself. Indeed at sphere radii comparable to the mean range of the electrons (c.a. 
185 µm), the losses are significant.       
 
Fig. 7: (a) The number of electrons initially generated and consequently emitted from 
the surface of spheres composed of Y-90 of increasing radii and (b) the associated power 
generated and emitted from the sphere. Insets: close up of response of smaller diameter 
spheres. In all cases the dashed red line represents beta particles generated within the 
sphere and the solid blue line represents beta particles emitted from surface of sphere. 
 
Fig. 8: The efficiency of microspheres composed of Y-90. Note the efficiency decreases 
with increasing sphere radii due to self-attenuation.  
Therefore, for the case of a microsphere comprised entirely of Y-90 with beta particles being 
randomly produced homogeneously and isotropically throughout the whole sphere, there is less 
than a 1 % error in the expected power output if self-absorption is neglected if the sphere radius 
is less than 6.5 µm. This rises to a 5 % error if the sphere radius is 40 µm and 10 % for a 91.5 
µm sphere radius. It is unlikely that spheres larger than this will be used in medical applications. 
Also in radioembolization therapies [1, 8], it is currently far more common for the microsphere 
to be comprised of Y-90 nanoparticles homogeneously dispersed in a glass or resin matrix. The 
above model can account for this, if it is assumed that all losses considered in eq. 10 are due to 
interactions with a single type of atom. Otherwise, the theory would have to be generalised to 
take into account the exact composition of the material. If it is assumed that the Y-90 is 
distributed at low density in glass, SiO2, in such a manner that any beta particle produced will 
only interact with the glass, which is assumed to have density 2650 kg/m3 and average atomic 
number 10 and mass 20u, then the effects of self-absorption can be modelled as above. The 
results are shown below in Fig. 9(a). As expected, beta particles lose less energy as they travel 
a given distance in glass as they would in Y-90. In this case, the effect of neglecting self-
absorption within the microsphere is less than 1 % for spheres with a radius less than 25 µm, 
which is true for most commonly used glass spheres [8]. It is expected that resin spheres will 
have a comparable response.        
 
 Fig. 9: (a) The efficiency of a microsphere comprised of pure Y-90 (blue solid line) 
compared to microspheres comprised of mostly glass with Y-90 as a beta source (blue 
crossed line). (b) The efficiencies of microspheres comprised of pure P-33 (black solid 
line) and of pure Lu-177 (red solid line) compared to microspheres comprised of mostly 
glass with P-33 (black crossed line) and Lu-177 (red crossed line) as a beta source. 
However, as also seen in Fig. 9(b), while self-absorption can be neglected for Y-90 
microspheres of a size used in most medical applications, this is not necessarily true for other 
medically relevant radioisotopes. This is because Y-90 emits high-energy beta particles. For 
comparison, as shown in Fig. 9, lutetium-177 (Lu-177) emits beta-minus particles of maximum 
energy 498 keV (average energy 0.149 keV) has a half-life of 6.73 days and is used for treating 
micro-metastatic disease and bone pain palliation [65]. For a microsphere comprised of pure 
Lu-177, the self-absorption effects are much more pronounced with 10 % losses expected for 
spheres with a 2 µm radius and 50 % losses for spheres with a 22 µm radius. Similarly, 
phosphorus-33 (P-33) emits beta-minus particles of maximum energy 249 keV (average energy 
0.085 keV) has a half-life of 25.4 days and is used for nucleotide labelling [66]. P-33 will 
deposit 10 % of its energy within a sphere of radius 8.5 µm and 50 % of its energy within a 
sphere of radius 100 µm. Therefore, the size of the microsphere can have an important effect 
on the actual energy emitted by a radionuclide. As mentioned above, it is common for 
radioisotopes to be encapsulated in glass or resin when used in radioembolization therapies. As 
for Y-90, the low density and atomic mass of the glass means that in the case of Lu-177, the 
effects of self-absorption are less pronounced in an encapsulated distributed source than for a 
single material source, with a sphere radius of 23 µm needed before a loss of 10 %. However, 
in the case of P-33, the situation is different. As the density of P-33, taken to be 1820 kg/m3, is 
less than glass, the self-absorption is actually higher when the microsphere is comprised of P-
33 distributed in a glass matrix with 10% energy loss within a radius of 7 µm.        
As discussed in the introduction, there have been several models formulated to calculate dose 
absorbed by various media in different geometries. The most frequently used is arguably that 
calculated by Berger [37, 50, 67] for a uniform volume distribution of sources emitting 
monoenergetic electrons with initial energy 0E . In this formulation, the energy absorbed by a 
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where ( )0 0,F x r E is the normalized ‘point dose kernel’ which represents the fraction of energy 
emitted by a monoenergetic point source absorbed within a spherical layer with a thickness dx  
at a distance x  from the source. 0r is the maximum range of the electron with initial energy 0E
and is used a normalisation constant. The normalised point kernel was taken from the work of 
Prestwich et al. [41] who fitted a non-physical function to data generated using Monte Carlo 
methods. Fitting data for Y-90 was supplied in [41] and used directly in Eq. 25. In [41] it was 
shown that the average deviation between the numerical data and the fitted function was within 
2 %. Interestingly, Prestwich et al. compared their data against to that calculated by Spencer 
[40] who solved transport equation in a manner comparable to the method proposed here. 
Prestwich et al. showed that for electrons with energy below 50 keV, the dose predicted was 
overestimated by 6 % by the transport equation and underestimated by 6 to 12 % for energies 
above 0.5 MeV. It was noted that discrepancies were mainly due to Spencer neglecting 
bremsstrahlung and energy straggling effects, which are both included here. Neither extended 
the theory for spherical sources. While Prestwich et al. data used Y-90 as an electron source, it 
assumes, as is common practice, that the energy dissipation is through interaction with water. 
Scaling Eq. 25 in a manner suggested by Cross [68] to take into account the larger atomic 
number of Y-90, the power emitted by a Y-90 sphere can be calculated. The comparison 
between the point-kernel formulation and the model proposed here is shown in Fig. 10. The 
maximum deviation between the two models over the 0-1 mm sphere radius range is 7.5 % 
with an average error of 4.4 %. This demonstrates that the proposed model can give accurate 
results for the power generated by nuclear microspheres without resorting to Monte Carlo 
calculations or curve-fitting/interpolation of tabulated data.   
 
Fig. 10: Comparison between power generated by Y-90 microsphere of various radii 
calculated using the proposed model (blue solid line) as shown in Fig. 7(b) and that 
calculated using the point dose kernel approach given by Eq. 25 (circled red line). Inset: 
close up of response of smaller diameter spheres.  
 
3. Conclusion 
In this paper, the effect of the finite size of beta producing radioactive microspheres on the rate 
of energy emitted and their efficiency has been shown. By utilising a continuous approximation 
approach, the energy losses that a beta particle experiences as it traverses the radioactive 
microsphere has been calculated. This result was combined with energy straggling effects by 
assuming a Rayleigh distribution which took into account the statistical nature of the actual 
range of the electron to calculate the mass attenuation coefficient, which in this case is the self-
attenuation coefficient. By using an analogy with spherical gamma emitters, the flux and power 
output at the surface of beta emitting microspheres was given. In order to give a numerical 
example, the specific case of yttrium-90, a medically important beta source, was considered. 
Thus the self-attenuation coefficient for Y-90 was calculated and it was shown that the energy 
absorbed by the sphere itself becomes significant at sphere radii comparable to the mean range 
of the beta particles. Results shown for Lu-177 and P-33 show that the self-attenuation effect 
is important for some radionuclides and medically applicable microsphere radii. It is shown 
that the standard practice of encapsulating beta sources in a glass matrix has a profound effect 
on the self-attenuation coefficient for the microsphere, with the energy loss actually being 
increased if the density of the matrix is higher than that of the pure beta source. Using the 
method suggested by this paper, the dose supplied by beta-emitting microspheres can now be 
calculated far more accurately, reducing the risk of further health issues caused by over/under 
exposure.      
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